Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2025-12-25 @ 8:16 PM
Study NCT ID:
NCT05304169
Status:
COMPLETED
Last Update Posted:
2022-03-31
First Post:
2022-03-11
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study to Evaluate the Safety and Efficacy of Switching From Zoladex® Monthly or Quarterly, to Eligard® Semiannual.
Sponsor:
Zodiac Produtos Farmaceuticos S.A.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-11-14
Start Date Type:
ACTUAL
Primary Completion Date:
2018-06-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-06-15
Completion Date Type:
ACTUAL
First Submit Date:
2022-03-11
First Submit QC Date:
None
Study First Post Date:
2022-03-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-21
Last Update Post Date:
2022-03-31
Last Update Post Date Type:
ACTUAL